J&J sees $400M tariff impact, mostly from exports to China: CFO
Johnson & Johnson (JNJ) reported a beat on first quarter earnings Tuesday, even as concerns linger about how President Trump's tariffs will impact its medical device business, as well as how a probe into pharmaceutical tariffs will impact its …